-- 
Pharmasset Rises on Positive Results for Hepatitis C Drug

-- B y   C h r i s   S t a i t i
-- 
2011-09-30T20:15:47Z

-- http://www.bloomberg.com/news/2011-09-30/pharmasset-rises-on-positive-results-for-hepatitis-c-drug.html
Pharmasset Inc. (VRUS)  shares rose to the
highest in more than four years after the drugmakerâ€™s PSI-7977
medication was shown effective at treating hepatitis C.  Pharmasset, based in Princeton, N.J., gained $5.07, or 6.6
percent, to $82.37 at 4 p.m. in Nasdaq Stock Market trading. It
is the highest share price since April 2007.  To contact the reporter on this story:
Chris Staiti in Boston at 
 cstaiti@bloomberg.net   To contact the editor responsible for this story:
Reg Gale at 
 rgale5@bloomberg.net  